Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

Recruiting

Nanodropper vs. Standard EyedropperUse of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

Sponsor:

University of Washington

Code:

NCT05277870

Conditions

Glaucoma, Open-Angle

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nanodropper adaptor

control

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Washington on 2022-03-14.